Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Ileen Gilbert, Keiko Wada, Chakkarin Burudpakdee, Chirag Ghai & Laren Tan. (2020) The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control. Patient Preference and Adherence 14, pages 1463-1475.
Read now
Read now
Arzu Ari. (2020) PROMOTING SAFE AND EFFECTIVE USE OF AEROSOL DEVICES IN COVID-19:RISKS AND SUGGESTIONS FOR VIRAL TRANSMISSION. Expert Opinion on Drug Delivery 17:11, pages 1509-1513.
Read now
Read now
Benjamin Greenberg, Steven Hall, Michael Grabner, Sanjeev Balu, Xian Zhang & Daniel Kantor. (2020) Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate. Current Medical Research and Opinion 36:7, pages 1167-1175.
Read now
Read now
Henry Chrystyn & Federico Lavorini. (2020) The dry powder inhaler features of the Easyhaler that benefit the management of patients. Expert Review of Respiratory Medicine 14:4, pages 345-351.
Read now
Read now
S Gaduzo, V McGovern, J Roberts, JE Scullion & D Singh. (2019) When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 391-401.
Read now
Read now
José Luis López-Campos, Esther Quintana Gallego & Laura Carrasco Hernández. (2019) Status of and strategies for improving adherence to COPD treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1503-1515.
Read now
Read now
Giulia Parri, Dario Nieri, Maria Adelaide Roggi, Barbara Vagaggini, Alessandro Celi & Pierluigi Paggiaro. (2018) Fluticasone furoate, umeclidinium bromide, and vilanterol as a combination therapy for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 12:12, pages 997-1005.
Read now
Read now
Felipe Villar-Álvarez, Raúl Moreno-Zabaleta, Jose Joaquin Mira-Solves, Eduardo Calvo-Corbella, Salvador Díaz-Lobato, Fernando González-Torralba, Ascensión Hernando-Sanz, Sara Núñez-Palomo, Sergio Salgado-Aranda, Beatriz Simón-Rodríguez, Paz Vaquero-Lozano & Isabel María Navarro-Soler. (2018) Do not do in COPD: consensus statement on overuse. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 451-463.
Read now
Read now
Irvin Mayers & Mohit Bhutani. (2018) Considerations in establishing bioequivalence of inhaled compounds. Expert Opinion on Drug Delivery 15:2, pages 153-162.
Read now
Read now
Klaus F. Rabe. (2017) GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond. Expert Review of Clinical Pharmacology 10:7, pages 685-698.
Read now
Read now
Diego Sangiorgi, Valentina Perrone, Stefano Buda & Luca Degli Esposti. (2017) Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study. Cogent Medicine 4:1.
Read now
Read now
Alessandro Roggeri, Claudio Micheletto & Daniela Paola Roggeri. (2016) Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 597-602.
Read now
Read now
Articles from other publishers (18)
Kristin V. Carson‐Chahhoud, Bruce R. Thompson & John W. Upham. (2022) Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes. Respirology 27:5, pages 328-330.
Crossref
Crossref
Tamara Alonso-Pérez, Elena García-Castillo & José Luis López-Campos. (2021) Escalando y desescalando el tratamiento en la enfermedad pulmonar obstructiva crónica. ¿El inhalador importa?. Archivos de Bronconeumología 57:9, pages 604-605.
Crossref
Crossref
Tamara Alonso-Pérez, Elena García-Castillo & José Luis López-Campos. (2021) Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?. Archivos de Bronconeumología (English Edition) 57:9, pages 604-605.
Crossref
Crossref
Ileen Gilbert, Aanam Aslam Mahmood, Katie Devane & Laren Tan. (2021) Association of Nonmedical Switches in Inhaled Respiratory Medications with Disruptions in Care: A Retrospective Prescription Claims Database Analysis. Pulmonary Therapy 7:1, pages 189-201.
Crossref
Crossref
Manuela Latorre, Giulia Parri & Pierluigi Paggiaro. (2020) Is adherence to treatment influenced by the ability to use inhaled devices in patients with COPD correctly?. Pulmonology 26:2, pages 63-65.
Crossref
Crossref
Sanjay Sethi, Igor Z. Barjaktarevic & Donald P. Tashkin. (2020) The use of nebulized pharmacotherapies during the COVID-19 pandemic. Therapeutic Advances in Respiratory Disease 14, pages 175346662095436.
Crossref
Crossref
Michael G. Kirby, Paula Allchorne, Tim Appanna, Patrick Davey, Richard Gledhill, James S. A. Green, Damian Greene & Derek J. Rosario. (2019) Prescription switching: Rationales and risks. International Journal of Clinical Practice 74:1.
Crossref
Crossref
Chloe I Bloom, Ian Douglas, Jack Olney, Grainne D'Ancona, Liam Smeeth & Jennifer K Quint. (2019) Cost saving of switching to equivalent inhalers and its effect on health outcomes. Thorax 74:11, pages 1078-1086.
Crossref
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
Crossref
Phil Reed. (2019) Previous mindfulness experience interacts with brief mindfulness induction when reducing stimulus overselectivity. Applied Cognitive Psychology 33:2, pages 265-271.
Crossref
Crossref
Alexander Kroll. (2018) Back to Basics in Asthma and COPD: Optimising the Patient Journey. EMJ Respiratory, pages 47-54.
Crossref
Crossref
Katarzyna Luczak-Wozniak, Marta Dabrowska, Izabela Domagala, Marta Miszczuk, Wojciech Lubanski, Andrzej Leszczynski & Rafal Krenke. (2018) Mishandling of pMDI and DPI inhalers in asthma and COPD – Repetitive and non-repetitive errors. Pulmonary Pharmacology & Therapeutics 51, pages 65-72.
Crossref
Crossref
Richard Dekhuijzen, Federico Lavorini, Omar S. Usmani & Job F.M. van Boven. (2018) Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?. The Journal of Allergy and Clinical Immunology: In Practice 6:3, pages 785-793.
Crossref
Crossref
Giorgio W. Canonica, Matteo Ferrando, Ilaria Baiardini, Francesca Puggioni, Francesca Racca, Giovanni Passalacqua & Enrico Heffler. (2018) Asthma: personalized and precision medicine. Current Opinion in Allergy & Clinical Immunology 18:1, pages 51-58.
Crossref
Crossref
Paola Rogliani, Josuel Ora, Ermanno Puxeddu, Maria Gabriella Matera & Mario Cazzola. (2017) Adherence to COPD treatment: Myth and reality. Respiratory Medicine 129, pages 117-123.
Crossref
Crossref
Job F.M. van Boven, Federico Lavorini, P.N. Richard Dekhuijzen, Francesco Blasi, David B. Price & Giovanni Viegi. (2017) Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy. European Respiratory Journal 49:5, pages 1700076.
Crossref
Crossref
Jo Riley & Phillip Krüger. (2017) Optimising inhaler technique in chronic obstructive pulmonary disease: a complex issue. British Journal of Nursing 26:7, pages 391-397.
Crossref
Crossref
Alessandra Bettiol, Jenny Bolcato, Roberta Pirolo, Giulia Franchin, Paola Deambrosis, Pietro Giusti & Alessandro Chinellato. (2016) Prevalence, Costs and Consequences of “Manovra AIFA” for ICS-LABA Treatment in Patients with Asthma or COPD: A Real-Practice Analysis. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 3:3, pages GRHTA.5000235.
Crossref
Crossref